An expanded-access program of Avastin [bevacizumab] in patients with metastatic cancer of the colon or rectum

Trial Profile

An expanded-access program of Avastin [bevacizumab] in patients with metastatic cancer of the colon or rectum

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Feb 2010

At a glance

  • Drugs Antineoplastics; Bevacizumab
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 18 May 2008 Status changed from in progress to completed, from Roche record.
    • 08 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top